Equities

After examining all of our analysts’ buy-rated global stocks, we have identified ten of them which we particularly like over the next 12 months or so for private clients.

Our analysts provide their sector outlook and top stock picks for 2023.

After examining all of our analysts’ buy-rated stocks with a market capitalisation above $1.0 billion, we have identified ten of them which we particularly like over the next 12 months or so for private clients.

The recent $30m placement significantly strengthens the PolyNovo balance sheet. We maintain a Buy rating, with a Price Target of $2.30.

BPT reported quarterly production of 5.2MMboe (BPe 5.4MMboe), down 8% QoQ, driven by major producing assets performing below expectations, particularly at Western Flank and the Victorian Otways.

CGC’s CY22e trading update quantifies the impact of the citrus quality issues while highlighting reasonable trading conditions across the remainder of the portfolio.